Investor Relations & Capital Introduction in Ghent

Ghent is one of Europe's leading biotechnology hubs and a major Flemish port and university city. For founders in life sciences, agricultural biotechnology and industrial technology, it offers world-class research and experienced specialist investors.

Why Ghent Matters for Capital Raising

The Flanders Institute for Biotechnology, VIB, was founded in 1996 and is headquartered in Ghent, supporting a strong pipeline of biotech spinouts.

Ghent University, founded in 1817, is one of Belgium's largest research universities, and the region has produced notable biotechnology companies.

North Sea Port, formed in 2018, links Ghent with Dutch ports and supports industry and logistics.

What Ghent Investors Examine

Scientific data, intellectual property and clinical or regulatory pathway are examined in detail.

Investors look for experienced leadership and international partnerships.

Engagement and Access

GCN connects founders with Ghent specialist life sciences funds, family offices and angel investors, alongside the Brussels investor community, through conference programming and private sessions.

Sectors where we see consistent Ghent interest include biotechnology, agricultural biotechnology, medical technology, industrial technology and logistics.

Partner with Global Capital Network

Whether you are raising into Ghent or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.